Global COVID-19 Saliva-based Screening Market Share, Supply, Analysis and Forecast To 2031
COVID-19 saliva-based screening is attaining traction in the existing situation, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. COVID-19 saliva-based screening plays a dynamic role in screening asymptomatic persons, thus sustaining market growth. This is mainly owing to numerous advantages offered by saliva-based tests, growing product approvals by FDA, and a shift toward point-of-care testing.
With the onset of the COVID-19 pandemic, several key players have entered the screening market. Advertising and expansion strategies are also playing an important role in generating market revenue. Furthermore, manufacturers are investing extensively in research & development activities to develop novel techniques that can allow rapid testing and accurate results.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32712
Product launches, approvals, and acquisitions & mergers are rampant in this market space:
Abbott launched ID NOW, a molecular POCT for detecting novel coronavirus (COVID-19), authorized by the U.S. FDA-issued Emergency Use Authorization (EUA). It is small, lightweight (6.6 pounds) and portable (size of a small toaster), and uses molecular technology that delivers positive results in as little as five minutes and negative results in 13 min.
In April 2021, Chembio Diagnostics, Inc. announced the launch of an FDA emergency use authorization-approved, in-licensed rapid POCT for COVID-19/Flu A&B test, for use in decentralized and traditional testing settings.
Thermo Fisher Scientific acquired Mesa Biotech, a developer of hand-held test devices for COVID-19 detection. Mesa received approximately US$ 450 Mn in cash and became eligible for an additional US$ 100 Mn based on the completion of certain pre-discussed milestones. This acquisition enabled Thermo Fisher Scientific to accelerate the availability of reliable and accurate advanced molecular diagnostics at POCT.
Thermo Fisher scientific
Takara Bio Inc
Arcis Biotechnology Limited
Lucence Health INc
Therma Bright Inc
ACON Laboratories, Inc
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Zymo Research Corporation.
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32712
Key Takeaways from Market Study
Based on product, saliva-based detection kits are leading with over 83% market share.
By technology, RT-qPCR technology holds around 49% market value share, globally, primarily due to increasing focus on rapid testing and growing research activities.
COVID-19 diagnostics is estimated to dominate the market by application. This segment accounted for approximately 63% share of the market, primarily due to rising prevalence of Covid-19 and increasing demand for COVID-19 diagnostics
Diagnostic laboratories dominate the market among the end users with a market share of 27%.
By region, Europe is set to dominate the global market with a value share of around 36%.
North America is slated to be the second-largest leading market with a value share of 34% through 2031.
"Increasing adoption of COVID-19 saliva-based screening, rising ageing population susceptible to COVID-19, and continuous guidance from governments to support the response effect of the pandemic are estimated to boost market growth over the coming years," says an analyst of Persistence Market Research.
New product approvals, launches, collaborations, agreements, and partnerships have emerged as the main growth strategy implemented by leading players. Acquisitions allow a company to expand its product portfolio. The company that is acquired possesses well-established diagnostic products and solutions, which become a good revenue source for the acquirer. This also enables the company to enter new emerging markets as well as existing markets.
In April 2021, Vatic Health received the CE mark for a saliva antigen test as an on-the-spot test for the SARS-CoV-2 virus. The test has also completed the Medicines and Healthcare Products Regulatory Agency (MHRA) registration in the U.K.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32712
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the COVID-19 saliva-based screening market in its latest study, presenting a historical demand assessment and projections for 2020 - 2031.
The research study is based on the product (saliva collection kits, saliva nucleic acid purification kit and saliva-based detection kits), technology (direct sample to PCR, RT-qPCR and lateral flow assay), application (COVID-19 research and COVID-19 diagnostics), end user (diagnostic laboratories, hospitals & clinics, academic and research institutes, biopharma companies, long term care facilities, home care settings and others), across seven key regions of the world.
Access PMR Exclusive Reports-
CCTV Camera Market- https://www.persistencemarketresearch.com/market-research/cctv-cameras-market.asp
Computer Accessories Market- https://www.persistencemarketresearch.com/market-research/computer-accessories-market.asp
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - firstname.lastname@example.org
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global COVID-19 Saliva-based Screening Market Share, Supply, Analysis and Forecast To 2031 here
News-ID: 2673339 • Views: 253
More Releases from Persistence Market Research
The Next Upcoming Years To See The Mineral Salt Ingredients Market Get Through T …
Persistence Market Research delivers key insights on the global mineral salt ingredients market in a newly published report titled "Mineral Salt Ingredients Market: Global Industry Analysis and Forecast, 2016 - 2024." In terms of revenue, the global mineral salt ingredients market is estimated to register a promising CAGR of 5.1% over the forecast period, owing to numerous factors, about which Persistence Market Research offers thorough insights and forecasts in this
The Industrial Fat Fraction Market To Grow With Rightsized Innovation Between 20 …
Persistence Market Research (PMR) has published a new report on the industrial fat fraction market titled "Industrial Fat Fraction Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025." The rising consumption of dairy products is fueled by the nutritional benefits associated with the consumption of these products. As per the Food and Agriculture Organization (FAO), approximately 150 million households are engaged in milk consumption at a
The Next Upcoming Years To Move Beyond Clichéd Roadmap With Innovations Between …
Increasing demand for white chocolates in food and beverage industry and cosmetics sector continues to be a key driving factor for the growth of the market. The various features of white chocolate, such as skin hydration, rich, variable textures, and superior taste is driving demand for white chocolates in the F&B, and cosmetics industry. Key market players such as Mars Incorporated, GCPPL Ltd., Nestle SA, Ghirardelli Chocolate Co., Mondelez International, Chocolatiers
The Casein Caseinate Market To Witness An Illustrious Growth Amidst Innovation B …
According to a new market report published by Persistence Market Research "Global Market Study on Casein and Caseinate: Industrial casein to be the Largest Sub-segment by 2025", the global casein & caseinate market was valued at US$ 2143.1 Mn in 2014 and is expected to expand at a CAGR of 4.7% to account for US$ 3564.4 Mn by 2025. The global casein & caseinate market is segmented on the basis